Erlotaz 150 Tablet

Erlotaz 150 Tablet

Therapeutic Class:
Get Quote

In Non-small cell lung cancer Non-small cell lung cancer is one of the major kinds of lung cancer and it affects both smokers as well as non-smokers. Erlotaz 150 Tablet helps treat non-small cell lung cancer and may be given alone or in combination with other medicines. It is a potent and very toxic medicine and you should discuss the risks and benefits with your doctor. You should avoid drinking alcohol while having this treatment and drink plenty of water to stay hydrated. In Pancreatic cancer Pancreas are very essential for digestion of whatever you eat and also for metabolism of blood sugar levels as they produce the body’s natural insulin. This medicine will help to control pancreatic cancer, and will relieve the symptoms such as, lack of appetite or unexplained weight loss. Erlotaz 150 Tablet helps to stop the action of those chemicals that aid in pancreatic cancer growth and spread. It will help you live a longer and healthier life. Erlotaz 150 Tablet is used in the treatment of non-small cell lung cancer and pancreatic cancer. Erlotaz 150 Tablet should be taken on an empty stomach or should be taken one hour before or 2 hour after meal. You should continue to take it as long as your doctor advises it. The duration of treatment varies according to your needs and response to treatment. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to. The most common side effects of this medicine include nausea, vomiting, fatigue, rash, and weight loss. It may cause severe diarrhea, drink plenty of fluids or consult with your doctor if it bothers you. It makes you sensitive towards sunlight, hence wear protective clothing or use sunscreen while going out. In case you develop ulceration in mouth, changes in your vision, or breathing difficulties than it is better to inform the doctor. Your doctor may advise for regular monitoring of liver function while you are taking this medicine. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy. It is advised to quit smoking while taking this medicine as it can affect the working of the medicine. If you have to take an antacid or any other medicine, take it at a gap of at least 2 hours after taking the cancer medicine.

Salt Composition: Erlotinib (150mg)
NA
Pack Size: bottle of 30 tablets
Uses: Non-small cell lung cancer | Pancreatic cancer
Table Header
Salt Composition
Erlotinib (150mg)
Strength
Pack Size
bottle of 30 tablets
Uses
Non-small cell lung cancer | Pancreatic cancer
DISCLAIMER
N Chimanlal Enterprises (www.pilcare.com) is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Erlotaz 150 Tablet which is also known as Erlotinib (150mg) and Manufactured by Khandelwal Laboratories Pvt Ltd. It is available in strength of Erlotaz 150 Tablet is supplied for Tenders/ Emergency imports/ Un – licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Click to know price.

Product information is meant for

WholesalersSuppliersExportersDoctorsMOH Tender SuppliesHospitalsBrandCROsComparator SuppliesGenericCooperate SourcingIndividual PatientsIndian Institutional Buyers
Recently Viewed
Categories
error:
×